OPR - Delayed Quote • USD MGNX Dec 2024 17.500 put (MGNX241220P00017500) Follow 5.90 0.00 (0.00%) At close: February 15 at 10:31 AM EST Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for MGNX241220P00017500 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: MGNX We're Hopeful That MacroGenics (NASDAQ:MGNX) Will Use Its Cash Wisely MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures MacroGenics, Inc. (NASDAQ:MGNX) Q4 2023 Earnings Call Transcript 12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds Q4 2023 MacroGenics Inc Earnings Call MacroGenics (MGNX) Q4 2023 Earnings Call Transcript Macrogenics Inc (MGNX) Reports Strong Financial Position and Advancements in Cancer Treatment ... MacroGenics (MGNX) Reports Q4 Loss, Lags Revenue Estimates MacroGenics Provides Update on Corporate Progress and 2023 Financial Results Insider Sell: COO Eric Risser Sells 41,159 Shares of Macrogenics Inc (MGNX) Are Investors Undervaluing MacroGenics, Inc. (NASDAQ:MGNX) By 48%? MacroGenics to Participate in Upcoming Investor Conferences
